Skip to main content
. 2022 May 23;12:894842. doi: 10.3389/fonc.2022.894842

Figure 2.

Figure 2

Enzyme inhibitory and antiproliferative activities of the derived APN inhibitors. a: APN enzyme inhibitory rates (A) of the synthesized compounds; (B) IC50 values of selected compounds; (C) antiproliferative activities of representative compounds in combination with chemotherapeutic drugs against MDA-MB-231 cells; (D) antiproliferative activities of representative compounds in combination with chemotherapeutic drugs against MDA-MB-468 cells; *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001.